| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avalo Therapeutics, Inc. (AVTX) has 9 insiders with recent SEC Form 4 filings, including 21 buys and 1 sell. AVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 275.0K | $4.04M | - | |
| Other | 47.8K | $702.7K | -679 | |
| CFO | 19.1K | $281.0K | - | |
| Other | 3.6K | $53.4K | - | |
| Dir | 3.2K | $46.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2020 | Armistice Capital, LLC56 | 10% Owner | Buy | 100,000 | $2.37 | $236,868.64 | - | |
| Sep 4, 2020 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 100,000 | $2.20 | $220,000.00 | +0.2% | |
| Jun 11, 2020 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 2,049,486 | $2.50 | $5,127,391.12 | +3.4% | |
| Jun 10, 2020 | Neil Garry Arthur | Chief Scientific Officer | Buy | 1,799 | $2.28 | $4,098.12 | +2.5% | |
| Jun 10, 2020 | Sullivan Christopher Ryan | Interim CFO | Buy | 2,954 | $2.28 | $6,729.21 | New | |
| Jun 10, 2020 | Harrell James Archie Jr | Chief Commercial Officer | Buy | 16,391 | $2.41 | $39,558.70 | +49.3% | |
| Jun 9, 2020 | Cola Michael F | Chief Executive Officer | Buy | 100,000 | $2.50 | $250,000.00 | +132.0% | |
| Apr 15, 2020 | Cerecor Inc. | 10% Owner | Sell | 92,777 | $1.55 | $144,091.96 | -0.9% | |
| Apr 3, 2020 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 4,280 | $2.16 | $9,244.80 | +0.5% | |
| Mar 31, 2020 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 111,914 | $2.37 | $265,345.68 | +4.9% |